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Abstract
Background: Many ‘routine’ interventions performed in hospital rooms have repercussions for the comfort of the
patient, and the decision to perform them should depend on whether the patient is identified as in a terminal
phase. The aim of this study is to analyse the health interventions performed and decisions made in the last days of
life in patients with advanced oncological and non-oncological illness to ascertain whether identifying the patient’s
terminal illness situation has any effect on these decisions.
Methods: Retrospective study of the clinical histories of deceased patients in four hospitals in Granada (Spain) in
2010. Clinical histories corresponding to the last three months of the patient’s life were reviewed.
Results: A total of 202 clinical histories were reviewed, 60 % of which were those of non-oncology patients. Opioid
prescriptions (58.4 %), palliative sedation (35.1 %) and Do Not Resuscitate (DNR) orders (34.7 %) were the decisions
most often reflected in the histories, and differences in these decisions were found between patients registered as
terminal and those who were not registered as terminal. The most frequent interventions in the final 14 days and
48 h were parenteral hydration (96–83 %), peripheral venous catheter (90.1–82 %) and oxygen therapy (81.2–70.
5 %). There were statistically significant differences between the patients who were registered as terminal and those
not registered as terminal in the number of interventions applied in the final 14 days and 48 h (p = 0.01–p = 0.00)
and in many of the described treatments.
Conclusion: The recognition of a patient’s terminal status in the clinical history conditions the decisions that are
made and is generally associated with a lower number of interventions.
Keywords: Decision making, Delivery of care, End-of-life care, Hospital care, Prognosis, Symptom management
Background
The experience of a patient at end of life is marked not
only by the symptoms suffered, but also by other factors,
such as the actions and decisions regarding treatment
taken by the professionals attending the patient [1, 2].
From a palliative point of view, in the final days, one
must consider a decision-making method that has
patient comfort as its primary objective and that man-
ages the efficacy and provision of treatments according
to this standard.
For physicians, the identification of a patient’s terminal
status should represent an inflection point to reflect upon
which measures to undertake or not, with the goal of avoid-
ing unnecessary suffering for the patient. However, studies
related to end-of-life decisions show the difficulties doctors
encounter in recognizing a patient’s proximity to death
and/or in noting this proximity in their reports [3–6]. The
motives for this difficulty appear to be related to fear of
making a mistake [7], the emotional ‘weight’ of the terminal
diagnosis [8, 9], and an optimistic attitude regarding the
patient’s prognosis [10, 11]. In this same vein, some studies
confirm that even in obviously advanced conditions,
patients were exposed to life-sustaining interventions and
practices, such as mechanical ventilation, transfusions,
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parenteral nutrition, extrarenal purification, etc., until the
end of life [12, 13].
Scientific literature informs the big decisions that dir-
ect a more intrusive or a more palliative treatment in a
terminal clinical situation. When speaking of end-of-life
decision-making, these appear to be centred basically in
crucial measures associated with medical aspects, such
as sedation, withdrawal of medication, refusal of admis-
sion to the intensive care unit (ICU), the omission or
withdrawal of antibiotics, hydration, or the use of mech-
anical ventilation [14, 16]. Similarly, the majority of the
studies conducted relate to patients who have died in
specialized ICUs [17–19].
However, in a context like the Spanish one, in which
the majority of patients in advanced and terminal states
are attended in hospital units in the weeks preceding
their death, decisions regarding the patient’s comfort re-
late to interventions that are considered routine.
Interventions such as the insertion of urinary and
intravenous catheters, the use of aspirators and other ac-
tions that are common for patient care in general hos-
pital units have not been considered in the literature on
decision-making in this type of context [20, 21], yet
these daily decisions can make the difference between
comfort and discomfort for these patients. The recom-
mended best clinical practice for these patients entails
limiting the use of actions that will not reduce their suf-
fering and allowing the unrestricted use of interventions
that can provide relief, such as providing opioids for
pain management and dyspnoea [22–25].
Taking these considerations into account, a descriptive
study was designed to review clinical histories to deter-
mine the relevant health interventions and decisions
performed in the final days of life in hospital rooms.
Similarly, the study aimed to determine whether the
registration of the patient’s terminal status had any effect
on these actions/decisions. Specifically, the objectives of
the present study were as follows:
1) To describe the decisions made in the final three
months of patients’ lives and the interventions
applied 14 days and 48 h before death.
2) To analyse these decisions andcompare the findings
for patients registered as being in the terminal stage
of illness with those for patients who were not
registered as terminal.
3) To compare the decisions made and interventions
provided during the final 14 days and 48 h of life in
terms of the moment at which the terminal phase
was registered.
Methods
A retrospective study was performed, evaluating the
clinical histories of patients who died between January 1
and December 1, 2010 in various public hospitals in the
province of Granada (Spain). The study was approved by
the ethics committee of each hospital.
Selection of clinical histories/sample
To calculate the sample size, a total population of 4031
deaths in hospitals and primary care settings was as-
sumed. For a 5 % precision in estimating the proportion
using a confidence interval with a normal asymptote
with correction for finite populations at 95 % bilaterally,
the estimated sample was 252 clinical histories.
Clinical histories were included for patients whose
causes of death, as recorded in the death records of the
hospitals’ documentation services, were ICD-9 diagnos-
tic codes related to advanced oncological and non-
oncological diseases Table 1.
The clinical histories were selected through the cen-
tres and were proportional to the number of patients
who died in each centre. Deaths that occurred within
24 h following hospital admission were excluded. We
also excluded 50 clinical histories of patients who died
at home after receiving care from primary care teams
because of differences in the format and type of data
registered by those teams compared with the data regis-
tered by hospitals.
Procedure
For the selection and identification of clinical histories,
the clinical documentation services of each hospital were
contacted. Additionally, data for the year 2010 were soli-
cited from the death registries of each hospital where
the basic cause of death included any of the aforemen-
tioned diseases Table 1.
The clinical histories were selected and reviewed dur-
ing the year 2011. The documents reviewed in the clin-
ical histories were the registration report and the
medical and nursing charts from the last 3 months of
the patients’ lives.
Three investigators performed the data collection. To
ensure the quality of the data collection and to ascertain
agreement in the valuation, a trial was conducted with
12 clinical histories in which certain items that were not
easily calibrated were purged and others whose interpre-
tations were unclear were redefined.
Socio-demographic variables were collected, as were
clinical data on the diseases. The study variables were
the notes in the clinical histories that allowed the identi-
fication of the patient’s terminal situation, which was
understood as an advanced illness in an evolved and
irreversible state with multiple symptoms, emotional
impact, loss of autonomy, little to no response to specific
treatments and a prognosis of death within weeks or
months within a context of progressive frailty [26].
We accepted all annotations that included explicit
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expressions related to this situation, such as ‘terminal’,
‘agony’, ‘bad prognosis’, and ‘palliative’. Meanwhile, the
interventions that the patient received in the final
days of life were concretely collected for two time pe-
riods: 14 days and 48 h before death. In addition,
socio-demographic variables were collected, as were
clinical data regarding the diseases.
Instrument
A data collection protocol was designed that included
the aforementioned variables. This document was agreed
upon by the investigative group of a broader project
called ‘Variability of Clinical Practice and Condi-
tional Factors in the Implementation of the Processes
of Attention at End of Life’, in which the present work
is included Table 1.
Data analysis
A descriptive analysis of the principle variables studied
was conducted. For the quantitative variables, the
means, medians, and standard deviations were calcu-
lated. The qualitative variables are expressed using abso-
lute and relative frequencies. To represent the data,
frequency tables and figures are used.
To ascertain the existence of significant differences
among the groups formed using the variables studied
(i.e., patients who were registered as being in the ter-
minal stage of illness versus patients who were not regis-
tered as such), Student’s T-test was used for independent
samples, and the Pearson chi-squared test or Fisher’s
exact test were used as appropriate for the qualitative
variables. For all of the contrasts, a significance level of
p ≤ 0.05 was considered.
Results
Description of the sample
The sample consisted of a total of 202 clinical histories
that met the inclusion criteria. The characteristics of the
patients’ deaths are shown in Table 2. Regarding the
cause of death, 60 % (n = 121) of the clinical histories
Table 1 Data collection protocol
Socio-demographic variables and Clinics
Sex
Age
Cause of death ICD-9 diagnostics dispatched in
the death records of the
documentation services of the
hospitals included in the study.
Oncological disease: 140–195;
196–198; 199; 200–208
Cardiac insufficiency: 402.0.1; 402.11;
402.91, 404; 428; 428.1
Hepatic insufficiency: 571; 572
Respiratory insufficiency/COPD:
491.21; 518.84
Chronic renal insufficiency: 585
Date of death Dispatched in the death records
of the documentation services of
the hospitals included in the study
Time elapsed since patient was
diagnosed




Comorbidity according to the
Charlson index
Individually calculated for each
patient as a function of the diverse




Dispatched in the death records of
the documentation services of the
hospitals included in the study
Hospitalisation Number of hospital admissions,
final three months of life
Number of days of the final
hospital admission
Medical end-of-life decisions in the final 3 months of life
Notation of the decision marked
in the clinical history and date at




- Continuation of care in home
- Consult or referral to palliative care
- Withdrawal or non-issuance of a
determined treatment/intervention.
- Decision of withholding/
withdrawing interventions
- Not running diagnostics tests
- Withdrawal of medication
- Withdrawal or non-issuance of
antibiotic
- Rejection of ICU consult or
rejection of ICU ingress
- Initiation of opioid medication
- Initiation of sedation
- Do Not Resuscitate order
Interventions performed in the final 14 days and 48 h
These interventions were
performed at least once in the





- Central venous catheter
















Identification of the clinical terminal situation in the final three months
of life
Identification of the terminal
situation of the patient and the





Express notation of terminality noted
in the clinical histories and date at
which the notation is first produced.
Other expression(s) used by
clinicians to refer to terminality, such
as agony, bad prognosis, palliative,
and date first produced.
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were those of non-oncological patients; of these, 22 %
(n = 45) were cardiac insufficiency, 20 % (n = 40) were
respiratory insufficiency/chronic pulmonary obstructive
disease (COPD), 11 % (n = 22) were hepatic insufficiency
and 7 % (n = 14) were chronic renal insufficiency. The
rest of the clinical histories were of oncological patients
(40 %, n = 81).
Regarding the hospitalization of the patients, 2 % (n = 4)
of patients were hospitalized at three months, 50.5 % at
14 days (n = 102), and 100 % (n = 202) at 48 h before
death. During the last three months of life, 70 % of
patients had one hospital admission, 22.8 % were admitted
on two occasions, and 6.4 % were admitted on three occa-
sions. On average, the patients stayed in hospital 13 days
(interquartile range 17–22) during their final admission,
during which they died.
Medical end-of-life decisions registered in the clinical
histories
Figure 1 shows the number and the total percentage of
clinical histories in which the decision was explicitly re-
corded, along with the average number of days until the
moment of death.
The prescription of opioids was the decision most
frequently recorded in the clinical histories, with
58.4 % (n = 118), followed by palliative sedation with
35.1 % (n = 71) and Do Not Resuscitate (DNR) orders
with 34.7 % (n = 70).
Decisions that were made earlier included the omis-
sion or withdrawal of dialysis, with a median of 15 days
(SD = 19.84); referral to the palliative care unit, with a
median of 10.50 days (SD = 22.91); and transfer to pallia-
tive care, with a median of 10 days (SD = 19.65).
Decisions that were made later, at a median of
1 day, were palliative sedation (SD = 6.35), withdrawal
of medication (SD = 4.46) and refusal of ICU admis-
sion (SD = 9.01).
Interventions provided during the final 14 days and 48 h
of life
The interventions documented in the clinical histories in
the final 14 days and 48 h of life are shown in Fig. 2.
The most frequently recorded interventions in the
final 14 days and 48 h of life, respectively, were paren-
teral hydration, with 96 % (n = 194) and 83 % (n = 166); a
peripheral venous catheter, with 90.1 % (n = 182) and
82 % (n = 164); and oxygen, with 81.2 % (n = 164) and
70.5 % (n = 141).
Registry of the terminal situation in the clinical histories
In 51.5 % (n = 104) of the clinical histories, some
language that identified the patient as being in a
terminal phase was observed. The median duration
between the registration of the patient as terminal
and the date of death was 5 days (min 1-max 90).
Some 68.27 % (n = 71) of these terminal patients were
registered before the 48 h immediately preceding their
deaths, and the other 31.73 % (n = 33) were identified
as terminal in the final 48 h.
The group of patients registered as terminal
showed characteristics that were similar to the pa-
tients who were not registered except for the type of
disease, in which significant differences were present
between oncology patients and non-oncology pa-
tients (p = 0.003).
Table 2 Characteristics of the patients who were registered as terminal and those who were not
Variables Total
N = 202





Age 72.81 years 72.13 years 73.56 years 0.470
(SD = 13.85) (SD = 14.69) (SD = 12.91)


























Time elapsed since patient
was diagnosed













Comorbidity Low comorbidity High comorbidity Low comorbidity High comorbidity Low comorbidity High comorbidity 0.626
13.2 % (n = 22) 86.8 % (n = 145) 14.5 % (n = 12) 85.5 % (n = 71) 11.9 % (n = 10) 88.1 % (n = 74)
p ≤ 0.05
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Comparison of the decisions related to end-of-life care in
patients who were and were not registered as in terminal
illness situation
Table 3 shows the frequency of decisions related to end-
of-life that were made in the last 14 days of life and were
registered in the clinical histories of the patients regis-
tered as terminal and those who were not. Significant
differences were observed between the two groups re-
garding decisions to discontinue medications (p = 0.000)
and to provide DNR orders (p = 0.002), palliative sed-
ation (p = 0.011) and opioids (p = 0.002).
Similarly, the frequency of decisions registered in the
clinical histories related to end-of-life care was analysed
for the last 48 h of life for the patients registered as ter-
minal and those who were not. Comparisons were made
between decisions to provide palliative sedation, to pre-
scribe opioids, and to discontinue medication; only the
decision to discontinue medication showed significant
differences (p = 0.002).
Regarding the time points at which decisions were
registered in the clinical histories, medical decisions
registered in the last 48 h of life were compared for
the patients who were registered as terminal before
their final 48 h (n = 71) and those who were regis-
tered later (n = 33). Considering palliative sedation,
opioid prescription, and the discontinuation of medi-
cation, significant differences were only found for opi-
oid prescriptions (p = 0.023).
Comparison of the interventions performed for patients
registered as terminal and those who were not
For the patients who were registered as terminal (n = 104),
the average number of interventions in the final 14 days
was six (min 0-max 22), and the average in the final 48 h
Fig. 1 Medical end-of-life decisions registered in clinical histories. * Oncological diseases N=81
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was five (min 0-max 14). For the patients who were not
registered as terminal (n = 98), the average was seven in-
terventions (min 3-max 21) in the final 14 days and six in-
terventions (min 1-max 14) in the final 48 h.
When comparing the number of interventions per-
formed in the final 14 days and 48 h of life between the
patients registered as terminal and those who were not,
independent of the time point at which this registration
was made, we found statistically significant differences
for both the final 14 days (p = 0.010) and the final 48 h
(p = 0.001).
The frequencies of the interventions performed in the
final 14 days and 48 h of life for the patients registered
as terminal and those who were not and a comparison
between the two groups are outlined in Table 4.
Of the total number of patients registered as ter-
minal (n = 104), 68.3 % (n = 71) were registered before
the final 48 h of life and the rest, 31.7 % (n = 33),
were registered during the final 48 h. The patients
registered as terminal before their final 48 h (n = 71)
underwent an average of four interventions in their
final 48 h, while those who were registered as ter-
minal during their final 48 h (n = 33) received an
average of six interventions; the difference between
the groups is significant (p = 0.002). Regarding the dif-
ferences in the frequency of various interventions be-
tween the groups, significant differences were only
found for the application of aerosols (p = 0.009). In
Table 5, the frequency of interventions for both
groups is shown.
Discussion
The objective of the present study was to analyse the in-
terventions provided and decisions made in the final
days of life and to determine whether registering the pa-
tient’s terminal status had an effect on the implementa-
tion of these measures. The results appear to show that
in the final days of the patient’s life, there is intense
therapeutic activity, and this activity is affected by the
registration of the terminal phase of the disease in the
patient’s clinical history.
In the clinical histories, a great number of ‘routine’
procedures, including parenteral hydration, antibiotics,
oxygen, insertion of peripheral venous catheters and
urinary catheters, are documented in the final days of
the patient’s life. In this sense, our results are consistent
with those of other studies centred on patients who died
in hospitals during acute disease treatment, in which a
greater intensity of interventions were registered at the
ends of the patients’ lives [27–29].
Approximately half of the clinical histories include
some term that identifies the patient as being in a
terminal state, and very few of these clinical histories
register this information early. This generalized delay
is demonstrated in a considerable number of publica-
tions [30, 31].
The identification of the terminal status is related to
the decrease in the total number of interventions in the
final days of life of the patient. In this sense, the study of
Hui et al. [13] shows that the early establishment of the
situation of terminal disease in patients with cancer is
Fig. 2 Interventions performed in the final 14 days and 48 h
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associated with changes in clinical practice, along with
improvements in the quality of care.
According to the results of this study, despite the low
frequency of some interventions, we can note that there
is not much difference in implementation of interven-
tions such as urinary or nasogastric intubation or central
or peripheral intravenous catheterisation between pa-
tients who are registered as terminal and those who are
not. These results concur with other studies, revealing
that even in manifestly terminal conditions, patients were
submitted to aggressive measures and important delays in
the establishment of palliative objectives [12, 32]. All the
same, it is necessary to perform a study with more partici-
pants to further support these conclusions.
Measures such as oxygen therapy or hydration deserve
special mention, as they can be a clear indication of
symptom control. There has been much controversy
over hydration and its usefulness at the end of life; how-
ever, there is currently sufficient evidence to affirm that
hydration does not have positive effects on the patient’s
quality of life, nor does it prolong survival [14, 33–36].
Regarding decisions associated with the end of life,
we observed that the prescription of opioids and
palliative sedation and DNR orders were the most fre-
quently noted.
DNR orders appeared in an important number of
clinical histories, both for patients who were registered
as being in a terminal illness situation and those who
were not. Nonetheless, the proportion found in the
present study was lower than in other studies and was
documented later in the patient’s illness [13, 27, 37, 38].
Carrion’s [39] study found that a DNR order has an ef-
fect on the plan of care; the variations found after sign-
ing a DNR order included the withdrawal of treatments
Table 3 End-of-life medical decisions made in the final 14 days and 48 h of life for patients who were registered as terminal and
those who were not













n = 104 n = 98 n = 104 n = 98
n (%) n (%) n (%) n (%)
Transfer to home 5 (4.8 %) 3 (3.1 %) 2 (1.9 %) 0 (0 %)
Transfer to a care home 5 (4.8 %) 8 (8.2 %) 0 (0 %) 1 (1 %)
Palliative consult 14 (13.5 %) 8 (8.2 %) 3 (2.9 %) 1 (1 %)
Referral to palliative care unit 8 (7.7 %) 6(6.1 %) 1 (1 %) 1 (1 %)
Transfer to palliative care unit 9 (8.7 %) 4 (4.1 %) 0 (0 %) 0 (0 %)
Decision of withholding/withdrawing interventions. 12 (11.5 %) 5 (5.1 %) 5 (4.8 %) 3 (3.1 %)
Withdrawal of or not starting artificial nutrition 4 (3.8 %) 1 (1 %) 2 (1.9 %) 0 (0 %)
Withdrawal of or not prescribing parenteral
hydration
5 (4.8 %) 0 (0 %) 3 (2.9 %) 0 (0 %)
Withdrawal of or not starting mechanical
ventilation
6 (5.8 %) 6(6.1 %) 5 (4.8 %) 5 (5.1 %)
Withdrawal or non-prescription of antibiotics 12 (11.5 %) 1 (1 %) 9 (8.7 %) 1 (1 %)
Not running diagnostic tests 7 (6.7 %) 0 (0 %) 1 (1 %) 0 (0 %)
Withdrawal of medication 29 (27.9 %) 5 (5.1 %) 20 (19.2 %) 5 (5.1 %)
Not entering into or consulting ICU 6 (5.8 %) 5 (5.1 %) 4 (3.8 %) 4 (4.1 %)
Do Not Resuscitate order (DNR) 36 (34.6 %) 15 (15.3 %) 9 (8.7 %) 7 (7.1 %)
Prescription of palliative sedation 38 (36.5 %) 20 (20.4 %) 28 (26.9 %) 15 (15.3 %)
Prescription of opioids 57 (54.8 %) 32 (32.7 %) 21 (20.2 %) 15 (15.3 %)
No aggressive measures 3 (2.9 %) 1 (1 %) 2 (1.9 %) 0 (0 %)
Prescription of comforting measures 14 (13.5 %) 7 (7.1 %) 8 (7.7 %) 4 (4.1 %)
Conservative treatment 3 (2.9 %) 1 (1.0 %) 2 (1.9 %) 0 (0 %)
Withdrawal of or not prescribing active
oncological treatment (oncology patients n = 81)
3 (5.8 %) 1 (3.4 %) 2 (1.9 %) 0 (0 %)
Withdrawal of or not prescribing dialysis 2 (1.9 %) 0 (0 %) 0 (0 %) 0 (0 %)
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and modifications in respiratory support and the admin-
istration of vasoactive drugs and dialysis.
Palliative sedation was noted in a high percentage of
clinical histories compared with the rest of the end-of-
life decisions and was also documented at a later time in
the patient’s illness. This finding coincides with the lit-
erature, which indicates that sedation is a frequent
measure and is often applied late in the patient’s illness
[3, 15, 40]. The pressure that family members place on
the physician, insistently demanding sedation to alleviate
the symptoms and to avoid having to witness their ill
family member’s suffering, can condition its implemen-
tation [41]. In this sense, some studies indicate that the
burden of responsibility that family members sometimes
Table 4 Comparison of the interventions performed in the final 14 days and 48 h in patients registered and not registered in a
terminal situation
Interventions Interventions in the final 14 days Interventions in the final 48 h
Registered terminal situation Registered terminal situation
Yes No P Yes No P
n = 104 n =98 n = 104 N = 98














































































































































































– 1 (1 %) 2 (2.1 %) –
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feel regarding the decision to use palliative sedation gen-
erates significant feelings of anxiety [42].
It is important to note that medical end-of-life
decisions are registered very late in clinical histories. A
great number of decisions were documented with a
mean time before death equal to or less than 48 h. Any
documentation of medical end-of-life decisions with a
mean time before death greater than 14 days was almost
non-existent.
However, it is interesting to note the great percentage
of end-of-life decisions that were documented in clinical
histories that did not include an explicit recognition of
the terminal status, which suggests that in many cases,
formal recognition of the terminal situation in the clin-
ical history is not necessary to produce certain decisions
closely related to the end of life.
Regarding the time point at which the terminal situ-
ation is registered, it is notable that with the exception
of a higher rate of opioid prescription, no differences
were observed in the application of interventions or pro-
fessionals’ decisions in relation to whether the patient’s
terminal status was registered in the clinical history.
Regarding limitations, the first to note are those inher-
ent in conducting a retrospective study.
Second, regarding this research, terminal illness situ-
ation was considered according only the data reported in
the clinical histories reviewed. This means that patients
or caregivers were not necessarily aware of this situation
at the time of data collection.
Third, the included clinical histories were selected
based on cause of death, allowing for a certain num-
ber of clinical histories that were not reviewed, as
they did not indicate the patient’s underlying disease
as the cause of death.
Finally, it is worth noting that the low frequency of
implementation of the decisions and interventions that
were registered impeded the use of a parametric analysis,
which limited the ability to extrapolate some of the
results obtained in this study.
Conclusions
The results of this research highlight that the care
received in hospital environments by patients who are in
the terminal phase of their disease is characterized by
the continuation of numerous interventions and thera-
peutic decisions that are typical for acute disease and far
from the objectives of palliative care. When there is an
explicit reference to the terminal phase of a disease in
Table 5 Interventions performed for patients registered as terminal with respect to the registration time point





n % n %
Urinary catheter 46 64.8 % 23 69.7 %
Central venous catheter 11 15.5 % 7 21.2 %
Peripheral venous catheter 58 81.7 % 31 93.9 %
Nasogastric tube 8 11.3 % 6 18.1 %
Enteral nutrition 3 4.2 % 4 12.1 %
Parenteral nutrition 6 8.4 % 4 12.1 %
Non-invasive mechanical ventilation 1 1.4 % 3 9 %
Invasive mechanical ventilation 1 1.4 2 6.1 %
Transfusions 2 2.8 % 5 15.1 %
Aspirator 7 9.8 % 3 9 %
Aerosols 20 28.2 % 18 54.5 %
Oxygen therapy 43 60.5 % 25 75.7 %
Hydration 55 77.5 % 26 78.8 %
Antibiotics 23 32.4 % 17 24 %
Drainage 6 8.45 % 4 12.1 %
Catheterisation 0 0 % 1 3 %
ICU consult 3 4.2 % 4 12.1 %
ICU ingress 3 4.2 % 5 15.1 %
Dialysis 2 2.8 % 1 3 %
Active oncological treatment (in oncology patients n = 81) 0 0 % 1 3 %
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clinical histories, the number of interventions is reduced,
and the number of end-of-life-related decisions is
increased. However, for many routine interventions,
patients continue to be treated like any other patient
despite the registration of their terminal situation in the
clinical history.
According to these conclusions, it is necessary to
undertake without delay educational interventions to
improve the training of all professionals of acute care
hospitals involved in the care of patients in a terminal
illness situation. Secondly, it is also necessary to involve
health managers, in the implementation of interventions
and procedures to improve management of terminal
illness situation in hospital settings, including improving
data collected in clinical histories.
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